Last reviewed · How we verify

NCT02519985

Repeatability and Reproducibility of the ArcScan Insight 100 VHF Digital Ultrasound

Suspended NA Last updated 11 December 2023
What this trial tests

NA trial testing ArcScan Insight 100 very high-frequency digital ultrasound in Corneal Thickness Measurement in 40 participants. Suspended.

Timeline
1 November 2016
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorLondon Vision Clinic
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment40
Start date1 November 2016
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

London Vision Clinic

Who can join

21 and older, any sex, with Corneal Thickness Measurement or Epithelial Thickness Measurement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the repeatability and reproducibility of corneal (including corneal, epithelial, stromal, and LASIK flap thickness) and anterior segment measurements using the ArcScan Insight 100 very high-frequency digital ultrasound arc-scanner.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ArcScan Insight 100 very high-frequency digital ultrasound

Trials testing the same drug.

Other London Vision Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02519985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing